We are pleased to invite investors and analysts to participate in a live webinar on Wednesday, 29 November 2023, highlighting Roche`s digital efforts in the Pharma and Diagnostics value chain, covering the utilization of AI/ML in many aspects of our business and the utilization of advanced data analytics and computational biology in drug discovery.   Speakers Alan Hippe, Chief Financial and IT Officer Roche Aviv Regev, Global Head - gRED Scott Oloff, Global Head - Data & Analytics, pRED Moritz Hartmann, Global Head of Roche Information Solutions, Roche Diagnostics Kent Kost, Global Head of Diagnostics Operations, Roche Diagnostics 13:30 - 15:30 CET / 12:30 - 14:30 GMT 7:30 – 9:30 am EST / 4:30 – 6:30 am PST   The webinar will start with a presentation, followed by a Q&A session (live access to the speakers). The slides will be available for download at 12:30 CET on the day of the event. > click here   Access to virtual event (pre-registration required) Please pre-register for our webinar here*.   Should you be unable to register for the webinar due to your company IT policy, please send an e-mail to investor.relations@roche.com.   A replay of the webcast will be available via > ir.roche.com   *privacy notice   Best regards,

Bruno Eschli Head of Investor Relations

Gerard Tobin Investor Relations Officer

Roche Investor Relations
Dr. Bruno Eschli Phone: +41 61 68-75284 e-mail: bruno.eschli@roche.com	Dr. Sabine Borngräber Phone: +41 61 68-88027 e-mail: sabine.borngraeber@roche.com
Dr. Birgit Masjost Phone: +41 61 68-84814 e-mail: birgit.masjost@roche.com	Dr. Gerard Tobin Phone: +41 61 68-72942 e-mail: gerard.tobin@roche.com
Investor Relations North America
Loren Kalm Phone: +1 650 225 3217 e-mail: kalm.loren@gene.com

 

Attachment

• 231129_Reminder

get the latest news and updates to your inbox.